ResearcherUniversity of TsukubaActive in the last 2 years
Yuichi Hiroshima
Matched on ORCID iD 0000-0002-4040-0127; OpenAlex author ID A5045506047. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Pain response after palliative-intent radiotherapy for pancreatic cancer: a systematic review. First author DOI 10.1007/s10147-026-03163-3↗
- Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. Co-author DOI 10.1186/s12957-025-03992-y↗
- Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. Co-author DOI 10.1002/cam4.6611↗
- Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic duc… Co-author DOI 10.1016/j.suronc.2021.101542↗
- Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Co-author DOI 10.1016/j.radonc.2019.03.012↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hideyuki Sakurai · 4 shared papers, 2019–2025 · strength 0.58
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. DOI 10.1002/cam4.6611↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Haruko Numajiri · 4 shared papers, 2019–2025 · strength 0.58
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. DOI 10.1002/cam4.6611↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Kenji Makita · 1 shared paper, 2026 · strength 0.33
- Yoshiyuki Shioyama · 1 shared paper, 2026 · strength 0.33
- Tatsuya Oda · 2 shared papers, 2021–2025 · strength 0.30
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Osamu Shimomura · 2 shared papers, 2021–2025 · strength 0.30
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Yoshihiro Miyazaki · 2 shared papers, 2021–2025 · strength 0.30
- Paper Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. DOI 10.1186/s12957-025-03992-y↗
- Paper Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable… DOI 10.1016/j.suronc.2021.101542↗
- Masato Endo · 1 shared paper, 2025 · strength 0.19
- Kiichiro Tsuchiya · 1 shared paper, 2025 · strength 0.19
- Hiromitsu Nakahashi · 1 shared paper, 2025 · strength 0.19
- Yusuke Ohara · 1 shared paper, 2021 · strength 0.11
- Tsuyoshi Enomoto · 1 shared paper, 2021 · strength 0.11
- Yoshimasa Akashi · 1 shared paper, 2021 · strength 0.11
- Nobuyoshi Fukumitsu · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.